PUBLICATION

The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo

Authors
de la Rocha-Muñoz, A., Núñez, E., Vishwanath, A.A., Gómez-López, S., Dhanasobhon, D., Rebola, N., López-Corcuera, B., de Juan-Sanz, J., Aragón, C.
ID
ZDB-PUB-211022-29
Date
2021
Source
Communications biology   4: 1197 (Journal)
Registered Authors
Keywords
none
MeSH Terms
  • Animals
  • Embryo, Nonmammalian
  • Glycine Plasma Membrane Transport Proteins/genetics*
  • Glycine Plasma Membrane Transport Proteins/metabolism
  • Hedgehog Proteins
  • Rats
  • Rats, Wistar
  • Signal Transduction
  • Zebrafish
  • Zebrafish Proteins/genetics*
  • Zebrafish Proteins/metabolism
PubMed
34663888 Full text @ Commun Biol
Abstract
The identity of a glycinergic synapse is maintained presynaptically by the activity of a surface glycine transporter, GlyT2, which recaptures glycine back to presynaptic terminals to preserve vesicular glycine content. GlyT2 loss-of-function mutations cause Hyperekplexia, a rare neurological disease in which loss of glycinergic neurotransmission causes generalized stiffness and strong motor alterations. However, the molecular underpinnings controlling GlyT2 activity remain poorly understood. In this work, we identify the Hedgehog pathway as a robust controller of GlyT2 expression and transport activity. Modulating the activation state of the Hedgehog pathway in vitro in rodent primary spinal cord neurons or in vivo in zebrafish embryos induced a selective control in GlyT2 expression, regulating GlyT2 transport activity. Our results indicate that activation of Hedgehog reduces GlyT2 expression by increasing its ubiquitination and degradation. This work describes a new molecular link between the Hedgehog signaling pathway and presynaptic glycine availability.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping